Microarray analysis of host gene expression for comparison between naïve and HSV-1 latent rabbit trigeminal ganglia

Molecular Vision

Volumn 14, Issue , 2008, Pages 1209-1221

  Clement, Christian ^a   Popp, Michael P ^a   Bloom, David C ^a,c   Schultz, Gregory ^c,d   Liu, Li ^a,d   Neumann, Donna M ^a   Bhattachrjee, Partha S ^a   Hill, James M ^a,b,e  

^a Department of Ophthalmology ^*  (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

^e LSU EYE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARBOHYDRATE METABOLISM; CELL ADHESION; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE MUTATION; HERPES SIMPLEX VIRUS 1; HOST PATHOGEN INTERACTION; HOST RESISTANCE; IMMUNE RESPONSE; INNATE IMMUNITY; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; RABBIT; TRIGEMINUS GANGLION; UPREGULATION; VIRUS LATENCY;

ANIMALS; DOWN-REGULATION; GENE EXPRESSION PROFILING; HERPESVIRUS 1, HUMAN; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RABBITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRIGEMINAL GANGLION; UP-REGULATION; VIRUS LATENCY;

EID: 47249090989     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Wagner EK, Bloom DC. Experimental investigation of herpes simplex virus latency. Clin Microbiol Rev 1997; 10:419-43.
2. Whitley RJ. Herpes Simplex Viruses. In: Fields BN, Knipe DM, Howley PM, editors. Fields Virology. 3 ed. Philadelphia: Lippincott-Raven Publishers; 1996. p. 2297-342.
3. Shimeld C, Efstathiou S, Hill T. Tracking the spread of a lacZ-tagged herpes simplex virus type 1 between the eye and the nervous system of the mouse: comparison of primary and recurrent infection. J Virol 2001; 75:5252-62.
4. Marsden H. Herpes simplex virus in latent infection. Nature 1980; 288:212-3.
5. Jones C, Inman M, Peng W, Henderson G, Doster A, Perng GC, Angeletti AK. The herpes simplex virus type 1 locus that encodes the latency-associated transcript enhances the frequency of encephalitis in male BALB/c mice. J Virol 2005; 79:14465-9.
6. Roizman B, Spector D. The Induction of α Genes by the α-trans-Inducing Factor. In: Wagner EK, editor. Herpesvirus transcription and its regulation.Boca Raton: CRC; 1991. p. 17-28.
7. Laycock KA, Lee SF, Brady RH, Pepose JS. Characterization of a murine model of recurrent herpes simplex viral keratitis induced by ultraviolet B radiation. Invest Ophthalmol Vis Sci 1991; 32:2741-6.
8. Yaghoubi SS, Barrio JR, Namavari M, Satyamurthy N, Phelps ME, Herschman HR, Gambhir SS. Imaging progress of herpes simplex virus type 1 thymidine kinase suicide gene therapy in living subjects with positron emission tomography. Cancer Gene Ther 2005; 12:329-39.
9. Roizman B, Knipe DM. Herpes simplex viruses and their replication. In: Knipe DM, Howley PM, editors. Fields Virology.Philadelphia: Lippincott Raven Press; 2001. p. 2399-480.
10. Cook SD, Paveloff MJ, Doucet JJ, Cottingham AJ, Sedarati F, Hill JM. Ocular herpes simplex virus reactivation in mice latently infected with latency-associated transcript mutants. Invest Ophthalmol Vis Sci 1991; 32:1558-61.
11. Fraser NW, Spivack JG, Wroblewska Z, Block T, Deshmane SL, Valyi-Nagy T, Natarajan R, Gesser RM. A review of the molecular mechanism of HSV-1 latency. Curr Eye Res 1991; 10:1-13.
12. Fraser NW, Valyi-Nagy T. Viral, neuronal and immune factors which may influence herpes simplex virus (HSV) latency and reactivation. Microb Pathog 1993; 15:83-91.
13. Higaki S, Gebhardt BM, Lukiw WJ, Thompson HW, Hill JM. Effect of immunosuppression on gene expression in the HSV-1 latently infected mouse trigeminal ganglion. Invest Ophthalmol Vis Sci 2002; 43:1862-9.
14. Hill JM, Shimomura Y, Yamamoto Y, Gangarosa LP. The pharmacological characterization of HSV-1 ocular shedding: induction and attempted blockage. In: Kohno R, Nakajima A, editors. Herpesviruses and Virus Chemotherapy. Pharmacological and Clinical Approaches.Amsterdam: Excerpta Medical; 1985. p. 119-22.
15. Kwon BS, Gangarosa LP, Burch KD, deBack J, Hill JM. Induction of ocular herpes simplex virus shedding by iontophoresis of epinephrine into rabbit cornea. Invest Ophthalmol Vis Sci 1981; 21:442-9.
16. Myles ME, Alack C, Manino PM, Reish ER, Higaki S, Maruyama K, Mallakin A, Azcuy A, Barker S, Ragan FA, Thompson H, Hill JM. Nicotine applied by transdermal patch induced HSV-1 reactivation and ocular shedding in latently infected rabbits. J Ocul Pharmacol Ther 2003; 19:121-33.
17. Neumann DM, Bhattacharjee PS, Hill JM. Sodium butyrate: a chemical inducer of in vivo reactivation of herpes simplex virus type 1 in the ocular mouse model. J Virol 2007; 81:6106-10.
18. Sawtell NM, Thompson RL. Rapid in vivo reactivation of herpes simplex virus in latently infected murine ganglionic neurons after transient hyperthermia. J Virol 1992; 66:2150-6.
19. Hill JM, Shimomura Y, Dudley JB, Berman E, Haruta Y, Kwon BS, Maguire LJ. Timolol induces HSV-1 ocular shedding in the latently infected rabbit. Invest Ophthalmol Vis Sci 1987; 28:585-90.
20. Fawl RL, Roizman B. Induction of reactivation of herpes simplex virus in murine sensory ganglia in vivo by calcium. J Virol 1993; 67:7025-31.
21. Bloom DC. HSV LAT and neuronal survival. Int Rev Immunol 2004; 23:187-98.
22. Hill JM, Lukiw WJ, Gebhardt BM, Higaki S, Loutsch JM, Myles ME, Thompson HW, Kwon BS, Bazan NG, Kaufman HE. Gene expression analyzed by microarrays in HSV-1 latent mouse trigeminal ganglion following heat stress. Virus Genes 2001; 23:273-80.
23. Mester JC, Rouse BT. The mouse model and understanding immunity to herpes simplex virus. Rev Infect Dis 1991; 13:S935-45.
24. Decman V, Freeman ML, Kinchington PR, Hendricks RL. Immune Control of HSV-1 Latency. Viral Immunol 2005; 18:466-73.
25. Khodarev NN, Advani SJ, Gupta N, Roizman B, Weichselbaum RR. Accumulation of specific RNAs encoding transcriptional factors and stress response proteins against a background of severe depletion of cellular RNAs in cells infected with herpes simplex virus 1. Proc Natl Acad Sci USA 1999; 96:12062-7.
26. Schillinger JA, Xu F, Sternberg MR, Armstrong GL, Lee FK, Nahmias AJ, McQuillan GM, Louis ME, Markowitz LE. National seroprevalence and trends in herpes simplex virus type 1 in the United States, 1976-1994. Sex Transm Dis 2004; 31:753-60.
27. Kaufman HE, Azcuy AM, Varnell ED, Sloop GD, Thompson HW, Hill JM. HSV-1 DNA in tears and saliva from normal adults. Invest Ophthalmol Vis Sci 2005; 46:241-7.
28. Popp MP, Liu L, Timmers A, Esson DW, Shiroma L, Meyers C, Berceli S, Tao M, Wistow G, Schultz GS, Sherwood MB. Development of a microarray chip for gene expression in rabbit ocular research 1. Mol Vis 2007; 13:164-73.
29. method. Methods 2001; 25:402-8.
30. Halford WP, Gebhardt BM, Carr DJJ. Persistent cytokine expression in trigeminal ganglion latently infected with herpes simplex virus type 1. J Immunol 1996; 157:3542-9.
31. Uhlar CM, Whitehead AS. Serum amyloid A, the major vertebrate acute-phase reactant. Eur J Biochem 1999; 265:501-23.
32. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340:448-54.
33. Murata H, Shimada N, Yoshioka M. Current research on acute phase proteins in veterinary diagnosis: an overview. Vet J 2004; 168:28-40.
34. Rozsa FW, Reed DM, Scott KM, Pawar H, Moroi SE, Kijek TG, Krafchak CM, Othman MI, Vollrath D, Elner VM, Richards JE. Gene expression profile of human trabecular meshwork cells in response to long-term dexamethasone exposure. Mol Vis 2006; 12:125-41.
35. Arend WP. Interleukin 1 receptor antagonist. A new member of the interleukin 1 family. J Clin Invest 1991; 88:1445-51.
36. Slunt HH, Thinakaran G. von KC, Lo AC, Tanzi RE, Sisodia SS. Expression of a ubiquitous, cross-reactive homologue of the mouse beta-amyloid precursor protein (APP). J Biol Chem 1994; 269:2637-44.
37. Wang P, Yang G, Mosier DR, Chang P, Zaidi T, Gong YD, Zhao NM, Dominguez B, Lee KF, Gan WB, Zheng H. Defective neuromuscular synapses in mice lacking amyloid precursor protein (APP) and APP-Like protein 2. J Neurosci 2005; 25:1219-25.
38. Wasco W, Gurubhagavatula S, Paradis MD, Romano DM, Sisodia SS, Hyman BT, Neve RL, Tanzi RE. Isolation and characterization of APLP2 encoding a homologue of the Alzheimer's associated amyloid beta protein precursor. Nat Genet 1993; 5:95-100.
39. Rygg M, Husby G, Marhaug G. Differential expression of rabbit serum amyloid A genes in response to various inflammatory agents. Scand J Inummol 1993; 38:417-22.
40. Strissel KJ, Girard MT, West-Mays JA, Rinehart WB, Cook JR, Brinckerhoff CE, Fini ME. Role of serum amyloid A as an intermediate in the IL-1 and PMA-stimulated signaling pathways regulating expression of rabbit fibroblast collagenase. Exp Cell Res 1997; 237:275-87.
41. He KL, Ting AT. A20 inhibits tumor necrosis factor (TNF) alpha-induced apoptosis by disrupting recruitment of TRADD and RIP to the TNF receptor 1 complex in Jurkat T cells. Mol Cell Biol 2002; 22:6034-45.
42. Ahn SG, Kim HS, Jeong SW, Kim BE, Rhim H, Shim JY, Kim JW, Lee JH, Kim IK. Sox-4 is a positive regulator of Hep3B and HepG2 cells' apoptosis induced by prostaglandin (PG)A(2) and delta(12)-PGJ(2). Exp Mol Med 2002; 34:243-9.
43. Akinbi HT, Epaud R, Bhatt H, Weaver TE. Bacterial killing is enhanced by expression of lysozyme in the lungs of transgenic mice. J Immunol 2000; 165:5760-6.
44. Bera A, Biswas R, Herbert S, Gotz F. The presence of peptidoglycan O-acetyltransferase in various staphylococcal species correlates wi th lysozyme resistance and pathogenicity. Infect Immun 2006; 74:4598-604.
45. Friess H, Ding J, Kleeff J, Liao Q, Berberat PO, Hammer J, Büchler MW. Identification of disease-specific genes in chronic pancreatitis using DNA array technology. Ann Surg 2001; 234:769-78.
46. Tapinos NI, Polihronis M, Thyphronitis G, Moutsopoulos HM. Characterization of the cysteine-rich secretory protein 3 gene as an early-transcribed gene with a putative role in the pathophysiology of Sjogren's syndrome. Arthritis Rheum 2002; 46:215-22.
47. Liao Q, Kleeff J, Xiao Y, Guweidhi A, Schambony A, Töpfer-Petersen E, Zimmermann A, Büchler MW, Friess H. Preferential expression of cystein-rich secretory protein-3 (CRISP-3) in chronic pancreatitis. Histol Histopathol 2003; 18:425-33.
48. Udby L, Calafat J, Sorensen OE, Borregaard N, Kjeldsen L. Identification of human cysteine-rich secretory protein 3 (CRISP-3) as a matrix protein in a subset of peroxidase-negative granules of neutrophils and in the granules of eosinophils. J Leukoc Biol 2002; 72:462-9.
49. Bals R. Epithelial antimicrobial peptides in host defense against infection. Respir Res 2000; 1:141-50.
50. Scott MG, Gold MR, Hancock RE. Interaction of cationic peptides with lipoteichoic acid and gram-positive bacteria. Infect Immun 1999; 67:6445-53.
51. Larrick JW, Hirata M, Balint RF, Lee J, Zhong J, Wright SC. Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein. Infect Immun 1995; 63:1291-7.
52. Koshland ME. The coming of age of the immunoglobulin J chain. Annu Rev Immunol 1985;3:425-53.
53. Mestecky J, McGhee JR, Immunoglobulin A. IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv Immunol 1987; 40:153-245.
54. Clement C, Tiwari V, Scanlan PM, Valyi-Nagy T, Yue BY, Shukla D. A novel role for phagocytosis-like uptake in herpes simplex virus entry. J Cell Biol 2006; 174:1009-21.
55. Mayer C, Grummt I. Ribosome biogenesis and cell growth: mTOR coordinates transcription by all three classes of nuclear RNA polymerases. Oncogene 2006; 25:6384-91.
56. Schmelzle T, Hall MN. TOR, a central controller of cell growth. Cell 2000; 103:253-62.
57. Cutler NS, Pan X, Heitman J, Cardenas ME. The TOR signal transduction cascade controls cellular differentiation in response to nutrients. Mol Biol Cell 2001; 12:4103-13.
58. Robinson EE, Foty RA, Corbett SA. Fibronectin matrix assembly regulates alpha5beta1-mediated cell cohesion. Mol Biol Cell 2004; 15:973-81.
59. Kent JR, Fraser NW. The cellular response to herpes simplex virus type 1 (HSV-1) during latency and reactivation. J Neurovirol 2005; 11:376-83.
60. Roizman B, Sears AE. An inquiry into the mechanisms of herpes simplex virus latency. Annu Rev Microbiol 1987; 41:543-71.
61. Gussow AM, Giordani NV, Tran RK, Imai Y, Kwiatkowski DL, Rall GF, Margolis TP, Bloom DC. Tissue-Specific Splicing of the Herpes Simplex Virus Type 1 Latency-Associated Transcript (LAT) Intron in LAT Transgenic Mice. J Virol 2006; 80:9414-23.
62. Higaki S, Deai T, Fukuda M, Shimomura Y. Microarray analysis in the HSV-1 latently infected mouse trigeminal ganglion. Cornea 2004; 23:S42-7.
63. Higaki S, Gebhardt BM, Lukiw W, Thompson H, Hill J. Gene expression profiling in the HSV-1 latently infected mouse trigeminal ganglia following hyperthermic stress. Curr Eye Res 2003; 26:231-8.
64. Divito S, Cherpes TL, Hendricks RL. A triple entente: virus, neurons, and CD8+ T cells maintain HSV-1 latency. Immunol Res 2006; 36:119-26.
65. Honda S, Farboud B, Hjelmeland LM, Handa JT. Induction of an aging mRNA retinal pigment epithelial cell phenotype by matrix-containing advanced glycation end products in vitro. Invest Ophthalmol Vis Sci 2001; 42:2419-25.
66. HamalainenHZhouHChouWHashizumeHHellerRLahesmaaR. Distinct gene expression profiles of human type 1 and type 2 T helper cells. Genome Biol20012(7):RESEARCH0022. Epub 2001 Jun 21 [PubMed: 11516335]
67. Kihara C, Tsunoda T, Tanaka T, Yamana H, Furukawa Y, Ono K, Kitahara O, Zembutsu H, Yanagawa R, Hirata K, Takagi T, Nakamura Y. Prediction of sensitivity of esophageal tumors to adjuvant chemotherapy by cDNA microarray analysis of gene-expression profiles. Cancer Res 2001; 61:6474-9.
68. Konu O, Kane JK, Barrett T, Vawter MP, Chang R, Ma JZ, Donovan DM, Sharp B, Becker KG, Li MD. Region-specific transcriptional response to chronic nicotine in rat brain. Brain Res 2001; 909:194-203.
69. Hayashida-Hibino S, Watanabe H, Nishida K, Tsujikawa M, Tanaka T, Hori Y, Saishin Y, Tano Y. The effect of TGF-beta1 on differential gene expression profiles in human corneal epithelium studied by cDNA expression array. Invest Ophthalmol Vis Sci 2001; 42:1691-7.